- Report
- February 2026
- 65 Pages
United States
From €4514EUR$4,995USD£3,874GBP
- Report
- February 2026
- 34 Pages
United Kingdom
From €4514EUR$4,995USD£3,874GBP
- Report
- February 2026
- 30 Pages
Spain
From €4514EUR$4,995USD£3,874GBP
- Report
- February 2026
- 32 Pages
South Korea
From €4514EUR$4,995USD£3,874GBP
- Report
- February 2026
- 29 Pages
Russia
From €4514EUR$4,995USD£3,874GBP
- Report
- February 2026
- 32 Pages
Mexico
From €4514EUR$4,995USD£3,874GBP
- Report
- February 2026
- 32 Pages
Japan
From €4514EUR$4,995USD£3,874GBP
- Report
- February 2026
- 30 Pages
Italy
From €4514EUR$4,995USD£3,874GBP
- Report
- February 2026
- 31 Pages
France
From €4514EUR$4,995USD£3,874GBP
- Report
- February 2026
- 35 Pages
China
From €4514EUR$4,995USD£3,874GBP
- Report
- February 2026
- 32 Pages
Brazil
From €4514EUR$4,995USD£3,874GBP
- Report
- August 2025
Global
From €768EUR$850USD£659GBP
- Report
- January 2025
- 132 Pages
Global
From €859EUR$950USD£737GBP
- Report
- December 2024
- 32 Pages
Brazil
From €4514EUR$4,995USD£3,874GBP
- Report
- December 2024
- 30 Pages
Mexico
From €4514EUR$4,995USD£3,874GBP
- Report
- December 2024
- 31 Pages
Japan
From €4514EUR$4,995USD£3,874GBP
- Report
- December 2024
- 32 Pages
China
From €4514EUR$4,995USD£3,874GBP
- Report
- December 2024
- 30 Pages
South Korea
From €4514EUR$4,995USD£3,874GBP
- Report
- December 2024
- 31 Pages
Russia
From €4514EUR$4,995USD£3,874GBP
- Report
- December 2024
- 31 Pages
Spain
From €4514EUR$4,995USD£3,874GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more